NeurosciencebioRxivPreprint
Alpha-synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
Tracy A. Cole, Hien Tran Zhao, Timothy J. Collier…·Katrina L. Paumier
This paper demonstrates that antisense oligonucleotides targeting SNCA reduce alpha-synuclein production, prevent pathology, and show translational potential in non-human primates.
10 citations